Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer

Scientific Reports
Qingyu XiaoHong Li

Abstract

The TMPRSS2:ERG gene fusion is the most prevalent early driver gene activation in prostate cancers of European ancestry, while the fusion frequency is much lower in Africans and Asians. The genomic characteristics and mechanisms for patients lacking ERG fusion are still unclear. In this study, we systematically compared the characteristics of gene fusions, somatic mutations, copy number alterations and gene expression signatures between 201 ERG fusion positive and 296 ERG fusion negative prostate cancer samples. Both common and group-specific genomic alterations were observed, suggesting shared and different mechanisms of carcinogenesis in prostate cancer samples with or without ERG fusion. The genomic alteration patterns detected in ERG-negative group showed similarities with 77.5% of tumor samples of African American patients. These results emphasize that genomic and gene expression features of the ERG-negative group may provide a reference for populations with lower ERG fusion frequency. While the overall expression patterns were comparable between ERG-negative and ERG-positive tumors, we found that genomic alterations could affect the same pathway through distinct genes in the same pathway in both groups of tumor types. Alt...Continue Reading

References

Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Apr 6, 2006·Cancer Research·Scott A TomlinsArul M Chinnaiyan
Apr 28, 2006·Nature Genetics·Michael ReichJill P Mesirov
May 29, 2007·The American Journal of Surgical Pathology·Sven PernerMark A Rubin
Jan 4, 2008·Cancer Research·Beth E HelgesonArul M Chinnaiyan
Feb 20, 2008·Neoplasia : an International Journal for Oncology Research·Scott A TomlinsArul M Chinnaiyan
Aug 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ying HuShiv Srivastava
Nov 26, 2008·Cancer Biology & Therapy·Andrew D DarnelTarek A Bismar
Feb 5, 2009·Cancer Research·Anuradha GopalanWilliam L Gerald
Feb 2, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Raquel EsguevaMark A Rubin
Feb 19, 2010·Nature·Rameen BeroukhimMatthew Meyerson
Jun 22, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Samson W FineVictor E Reuter
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Jul 30, 2010·Nature·Zhengyan KanSomasekar Seshagiri
Feb 11, 2011·Nature·Michael F BergerLevi A Garraway
Aug 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A RubinArul M Chinnaiyan
May 23, 2012·Nature Genetics·Christopher E BarbieriLevi A Garraway
Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andreas PetterssonLorelei A Mucci
Mar 16, 2013·Cancer Research·Lia BurkhardtRonald Simon
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Jun 14, 2013·European Urology·Christopher E BarbieriMark A Rubin
Feb 4, 2014·Genome Biology·Charity W LawGordon K Smyth
Mar 25, 2014·Endocrine-related Cancer·Delila Gasi TandefeltJan Trapman
Nov 5, 2014·Nature Genetics·Yasushi TotokiTatsuhiro Shibata
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
Jun 16, 2015·Lancet·Gerhardt AttardJohann S de Bono
Nov 1, 2015·Methods in Molecular Biology·Emmanuel BoutetIoannis Xenarios
Nov 5, 2015·Nucleic Acids Research·Alex H WagnerObi L Griffith
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Nov 22, 2015·Nucleic Acids Research·Min ZhaoZhongming Zhao
Dec 20, 2015·PloS One·Jennifer S MyersQing-Xiang Amy Sang

❮ Previous
Next ❯

Software Mentioned

R package voom
Genomatix software suite Analysis
MutSigCV
GISTIC
OncoPrint
limma

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.